We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Stem Cell Group Denies Selling Fraudulent Treatments

Law360, New York (January 17, 2017, 9:43 PM EST) -- A stem cell therapy provider accused of wrongfully marketing and selling stem cell treatments to patients nationwide told a California federal judge Monday to scrap the proposed fraud class action, calling it nothing more than a “fishing expedition.”

StemGenex Medical Group Inc. wants the court to dismiss the suit for failing to make any specific fraud allegations and for bringing conclusory claims against the defendants, which include some of StemGenex’s executives. The plaintiffs — people who were treated by StemGenex — have said that they wouldn’t...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.